Serum urate is most commonly determined by the phosphotungstate method of Folin and Dennis (1) or one of its many variations (2) (3) (4) (5) (6) . The enzyme uricase has also been used widely in urate determination, either by measuring the decrease in absorbance at 293 nm after uricase treatment (7, 8) or by measuring the reducing substances before and after uricase treatment, usually by a phosphotungstate method (9, 10) , or by coupling with peroxidase (11) . The reduction of alkaline ferricyanide has also been proposed (12, 13) and has recently been revived by Klein and Lucas (14) . We have recently proposed a procedure based on the acid reduction of the ferric ion in the presence of 1,10-phenanthroline (15) . This report describes a colorimetric procedure requiring as little as 20 zl of serum, an improved version of our previously described procedure (15) in which 2,4,6-tripyridyl-s-triazine (TPTZ) replaces 1, 10-phenanthrolmne.
This change requires a more complex buffer and increases reaction time, but sensitivity is doubled and interference by bilirubin is decreased at least fourfold. In addition, this report describes an ultraviolet procedure at 293 nm, in which ferricyanide, rather than uricase, is used to oxidize urate.
Materials and Methods

Colorimetric Procedure Reagents
Ferric chloride (0.02 mol/liter).
Dissolve 540 mg of FeCl3.6H20 in 100 ml of hydrochloric acid (0.16 ml of concd HC1 per 100 ml, 0.02 mol/liter).
TPTZ (8 mmol/liter (pH 4.95) . To 800 ml of de-ionized water, add 40 ml of acetone, 80 ml of methanol, 29 ml of glacial acetic acid, 12 g of sodium hydroxide, and 2 ml of "Triton X100"; pH should be 4.95 (adjust if necessary). Dilute to 1 liter.
Urdte standard.
Prepared as described previously (15) in a dialyzed serum base.
Procedure
To 2.5 ml of buffer, add and mix 0.5 ml of TPTZ and 0.1 ml of ferric chloride to prepare working reagent (final pH should be 4.75). Add and mix 50 or 20 l of serum and, after 8 mm, read at 593 nm (±20 nm) vs. reagent blank. Determine the urate concentration from a standard curve or from standards run along with the unknown. All data reported here, un- 
Prepared
as described by Gochman and Schmitz (11) .
Procedure
To 1 ml of serum, add 1 ml of perchloric acid reagent, mix well, and centrifuge to give clear supernate. To a 1-cm cuvet add 3 ml of oxidant, and to another 3 ml of blank reagent. Add 0. From the absorptivity of uric acid, the calculations are:
c(mg/dI) = 12600 (168.11) (1400)
To express the concentration in mol/dl, omit the factor 168.11 (mol wt of uric acid) from the calculation.
The calculation from a standard is as follows:
Results
Colorimetric Procedure
Reagent parameters.
The optimum pH for urate reduction of the ferric ion in the presence of TPTZ was found to be 4.75 (Figure 1 ). The influence of buffer molarity is shown in Figure 2 . Increasing molaity beyond 0.725 mol/liter impedes ferric reduction. The influence of TPTZ and ferric chloride concentrations are shown in Figures 3 and 4 , respectively. The optimum concentrations were found to be 1.2 mmol of TPTZ per liter and 0.6 mmol of ferric chlo- 
. Effect of TPTZ concentration on color development
Except for TPTZ concn, proposed procedure followed ride per liter. The influence of Triton X100, a nonionic surfactant, is shown in Figure 5 . The surfactant stabilizes color development and retards autoreduction. Methanol and acetone were required to stabilize TPTZ in solution in the working reagent. Acetone alone produced density striations, while methanol alone was inadequate to keep TPTZ in solution. The solvents also decreased the influence of buffer molarity ( Figure 2 ).
Reagent stability.
The working reagent is stable for about 4 h at room temperature and should not be Except for Triton concn, proposed procedure was followed refrigerated (refrigeration will cause TPTZ to precipitate).
Each component is stable indefinitely (at least eight months) at room temperature.
Color development.
Representative color development for low (4 mg/dl) and high (8 mg/dl) concentrations of urate and also for ferrous sulfate (190.4 lLmol/dl) is shown in Figure 6 . With urate, complete color development requires 8 mm. With ferrous sulfate, color development is complete within 2 mm. When urate was added to the reagent without TPTZ and incubated for 5, 10, 20, and 30 mm, followed by the addition of TPTZ, color development was not shortened, but remained at 8 mm. Evidently, urate reduction of ferric ions does not take place unless a ferrous chelating agent is present.
Linearity and sensitivity.
With 50-,d samples, the procedure is linear to about 12 mg/dl, and a representative standard curve is expressed by the equation A = 0.085c, where c is in mg/dl. With 20 il of serum, the procedure is linear to about 30 mg/dl and a representative standard curve is expressed by the equation A = 0.034c. The sensitivity (expressed as absorptivity, a) is 538, or e = 90400.
Accuracy and precision.
Within-run precision of the method was checked with 60 replicate assays each of "Calibrate" 1, 2, and 3 (General Diagnostics, Morris Plains, N. J. 07950). Means ±1 SD were 3.12 ± 0.03, 6.24 ± 0.06, and 9.41 ± 0.07, respectively.
Day-to-day precision was checked in the same manner with 30 replicate assays, each done 6 times over an eight-month period. Means ±1 SD were 3.12 ± 0.09, 6.21 ± 0.14, 9.39 ± 0.26. The CV for all determinations (720) was 2.6%. Recovery was 99.3%, ranging from 93.6% to 104.2% with 30 serial additions of 1 mg of urate per deciliter to a urate-free, dialyzed serum.
Interferences.
There are no protein effects between 1-12 g of albumin per deciliter, or in the presence of as much as 5 g of globulin per deciliter. Glucose (400 mg/dl), glutathione (50 mg/dl), salicylate (10 mg/ dl), and gentisic acid (10 mg/dl) do not interfere. There is no bilirubin interference to at least 20 mg/ dl. With a 50-gil sample, there is no ascorbate interference below 4 mg/dl; with a 20-Ml sample, none below 10 mg/dl ascorbate.
With a 50-M' sample, 100 mg of hemoglobin per deciliter produces a false elevation equivalent to 0.5 mg of urate per deciliter; with a 20-tl sample, 100 mg of hemoglobin per deciliter is equivalent to an apparent 0.2 mg of urate per deciliter. Formaldehyde (0.8 ml/dl) depresses recovery of urate by about 30%. Ferricyanide (3.5 zmol/ liter) depresses recovery by about 65%.
Ultraviolet Procedure
Reagent parameters.
The oxidation of urate by ferricyanide and ferric ions is shown in Figure 7 . The data indicate that alkaline (pH 11.3) ferricyanide rapidly oxidizes urate and is not notably effected by temperature.
At pH 7.5, however, the oxidation is slow, still slower at pH 4.8, and at pH 1 it does not occur. Ferric ions oxidize urate only at an acid pH and the oxidation is inhibited by increasing buffer molarity. The concentrations of ferric chloride and ferricyanide selected were based on the preceding colorimetric procedure and the paper of Klein and Lucas (14) , respectively.
Linearity
and sensitivity.
The procedure is linear to at least 15 mg/dl urate (see Figure 7 ) and the sen- . sitivity expressed as absorptivity is, of course, the absorptivity of urate at 293 nm, r = 12600 or a = 75.
Accuracy and precision.
The within-run precision of the method was checked with 60 replicate assays each of "Calibrate" reference sera 1, 2, and 3. Means ±1 SD were 3.06 ± 0.03, 6.15 ± 0.05, and 9.62 ± 0.08. Day-to-day precismon was checked in the same manner with 30 replicate assays, each done five times over a six-month period. Means ±1 SD were 3.05 ± 0.04, 6.12 ± 0.09, and 9.59 ± 0.14. The CV for all determmnatmons (630) was 1.2%. Recovery was 99.2%, ranging from 97.7% to 104.2% for 15 serial additions of 1 mg urate per deciliter to a urate-free, dialyzed serum.
Interference.
Protein interferes, and incomplete precipitation could cause problems. However, performing the procedure as described, I encountered no such problems. Ascorbate and glutathione do not interfere with oxidation of urate. Salicylate, which absorbs at 293 nm, is not oxidized by ferricyanide.
Discussion
The molar absorptivity (e) of the proposed TPTZ procedure (90 400) revealed, when compared to the molar absorptivity (22 600) of the ferrous-TPTZ complex (16) , that 4 moles of ferric ion were reduced for each mole of urate. Converting the absorptivity for the ferric-1, 10-phenanthroline procedure previously reported (15) to molar absorptivity, the same molar relationship was found. Curiously, however, aqueous urate standards reduced 2 moles of ferric ions, half of the reduction produced by urate standards in a dialyzed serum base which of itself had no reducing effect on ferric ions. Bulger and Johns (12) reported that, at 3 #{176}C, 1 mole of urate reduced 1 mole of alkaline ferricyanide.
Klein and Lucas (14) reported the same molar relationship at room temperature. However, in checking their data, it was found that the molar absorptivity for their procedure was 34800, twice the molar absorptivity of the ferrous benzodiazepin complex (17), indicating that, in fact, at 25 #{176}C, urate reduced 2 moles of alkaline ferricyanide. I checked this by repeating their procedure, except that I replaced benzodiazepin with TPTZ, and confirmed that 2 moles of ferricyanide were reduced. I also checked the molar absorptivity of the various chelates with ferrous sulfate and obtained the values reported in the literature.
These data are shown in Figure 8 . In contrast to the proposed acid oxidation of urate by ferric ions with a ferrous indicator ligand, whereby elevated temperatures do not increase the color produced but only decreased the reaction time (Fmgure 9), both Bulger and Johns (12) and Klein and Lucas (14) reported that elevated temperatures produced increased color with oxidation by alkaline ferricyanide. Using the Klein procedure (with TPTZ instead of benzodiazepin), I found that, with deproteinized serum, glucose and possibly other reducing substances begin to reduce alkaline ferricyanide above 40 #{176}C. Glucose does not effectively reduce fernc ions in a mild acid buffer, even at 100 #{176}C. With pure urate, elevated temperatures reduce erratic amounts of alkaline ferricyanide; but at about 90-100 #{176}C, near-maximum color is produced, which is equivalent to a total of 5 moles of ferricyanide reduced for each mole of urate. When commercial a!-Lantoin was heated with alkaline ferricyanide, 3 moles of ferricyanide were reduced for each mole of allantoin and 1.86 mole of urea and about 2 moles of formic acid were recovered. This suggests the relationship shown in Figure 10 .
Ferricyanide is more easily reduced at alkaline pH and cannot be reduced by serum constituents at pH 1. In contrast, ferric ions are more easily reduced at acid pH and are only very slowly reduced at alkaline pH. While ferricyanide reduction is not notably in1uenced by buffer molaity, ferric reduction is. At optimum pH (4.75) for acid oxidation of urate by erric ions a buffer is required, and, in the presence bf an adequate buffer concentration, the reaction does not take place unless a ferrous chelating ligand 's present. The rate of the reaction is primarily deendent on the ferric ion and ligand concentrations, mperature, and the affinity of the ligand for the errous ion. Both 1,10-phenanthroline and TPTZ are uitable, phenanthroline completing the reaction in 5 in and TPTZ in 8 min at room temperature. athophenanthroline disulfonate is unsuitable beause it has too high an affinity for ferrous ions, reulting in autoreduction of the reagent blank at a ate equivalent to about 0.2 mg of urate per deciliter er minute. Ferric ions are not reduced by urate or ther serum constituents at alkaline pH, even at igh temperatures (100 #{176}C), and in the presence of alkaline ferrous chelating ligand such as 4,7-dihyroxy-1, lO-phenanthrolmne.
Protein does not interfere th, but increases acid ferric ion reduction 100% stoichiometrically with the urate concentration. Since alloxan, with or without protein, does not reduce acid ferric ions, it appears that this phenomenon may be related to a possible association of urate with protein, although no clear explanation is apparent at the present time. Possibly, it is related to the formaldehyde interference noted in this study and by Klein and Lucas (17) . It may also be associated with the problem of poor recovery of added urate to serum in vitro noted by Caraway and Marable (10) . Studies are currently under way to evaluate this phenomenon. Protein reduced alkaline ferricyanide in relation to the protein content and not stoichiometrically with the urate concentration (4-8 g of protein is equivalent to 5-7 mg of urate per deciliter). Bilirubin does not effect acid ferric reduction, but reduces a!-kaline ferricyanide (1 mg of bilirubin is equivalent to about 0.2 mg of urate per deciliter). When urate is measured by its reducing properties, it appears that acid ferric reduction is more specific a reactant than is alkaline ferricyanide.
In examining the acid ferric reduction and alkaline ferricyanide reduction by urate, it appeared that alkaline ferricyanide could be used to oxidize urate, and the urate determined from the decrease in absorbance at 293 nm, in much the same way as is done in spectrophotometric uricase methods. It was found that this was feasible and the proposed ultraviolet procedure was developed.
After deproteinization with dilute perchioric acid, urate recovery was virtually complete and there was no interference with the ultraviolet measurement. Ferricyanide absorbs in the ultraviolet, but the absorbance at 293 nm does not impede measurements.
I took advantage of the fact that acid ferricyanide does not oxidize urate to combine the reagent blank with the serum blank. Although alkaline ferricyanide does not have the specificity of uricase, the procedure itself appears to be equally specific, undoubtedly because urate is the only serum constituent of consequence that both absorbs at 293 nm and is oxidi.zed by alkaline ferricyanide.
The proposed ultraviolet procedure is simpler than uricase methods in that it utilizes a combined blank and requires less than 15 mm. Be-cause of the expense and instability of uricase, most methods use low activities and require about 30 mm.
Both proposed methods were compared with the uricase method of Remp (8) and the phosphotungstate method of Caraway (2) . In comparing the TPTZ method against the uricase method, the regression. equation was y = 0.99x + 0.14, r2 = 0.97, S = ±0.20, n = 60; in contrast, against the phosphotungstate method the regression equation was y = 0.98x -0.52, r2 = 0.95, Sxy = ±0.34, n = 60. In comparing the ultraviolet ferricyanide method against the uricase method, the regression equation was y = 1.02x -0.13, r2 = 0.98, S = ±0.18, n = 60; against the phosphotungstate method the regression equation was y = 0.94x -0.16, r2 = 0.95, S, = ±0.36, n = 60. Thus, results by all the methods correlate well, but those with phosphotungstate average about 8% higher than those for either the TPTZ method or the ultraviolet ferricyanide procedure. The TPTZ and ultraviolet ferricyanide methods differ from the uncase method by <1%, except at low values (<2 mg/ dl), where TPTZ values run about 9% higher and those for ultraviolet ferricyanide run about 7% lower.
